Radiofrequency Ablation of Pulmonary Neoplasm Complicated by Pulmonary Hemorrhage

ABSTRACT

Pulmonary hemorrhage is a potentially serious complication of radiofrequency ablation of pulmonary neoplasms that may occur with or without hemoptysis. Several factors influence the development of parenchymal hemorrhage, including tumor size, tumor location, and procedural technique. As radiofrequency ablation has become more common, the prompt diagnosis and appropriate treatment of hemorrhage is vital. The authors report a case of radiofrequency ablation of a solitary pulmonary metastasis complicated by pulmonary hemorrhage and hemoptysis.

KEYWORDS

Radiofrequency ablation - lung - hemorrhage

REFERENCES

• 1 Rose S C, Thistlethwaite P A, Sewell P E, Vance R B. Lung cancer and radiofrequency ablation.  J Vasc Interv Radiol. 2006;  17 (6) 927-951, quiz 951
• 2 Fernando H C. Radiofrequency ablation to treat non-small cell lung cancer and pulmonary metastases.  Ann Thorac Surg. 2008;  85 (2) S780-S784
• 3 Dupuy D E, Zagoria R J, Akerley W, Mayo-Smith W W, Kavanagh P V, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung.  AJR Am J Roentgenol. 2000;  174 (1) 57-59
• 4 Akeboshi M, Yamakado K, Nakatsuka A et al.. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response.  J Vasc Interv Radiol. 2004;  15 (5) 463-470
• 5 Lencioni R, Crocetti L, Cioni R et al.. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).  Lancet Oncol. 2008;  9 (7) 621-628
• 6 Chua T C, Sarkar A, Saxena A, Glenn D, Zhao J, Morris D L. Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients.  Ann Oncol. 2010;  21 (10) 2017-2022
• 7 Gillams A R, Lees W R. Radiofrequency ablation of lung metastases: factors influencing success.  Eur Radiol. 2008;  18 (4) 672-677
• 8 Simon C J, Dupuy D E, DiPetrillo T A et al.. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.  Radiology. 2007;  243 (1) 268-275
• 9 Nour-Eldin N E, Naguib N N, Mack M, Abskharon J E, Vogl T J. Pulmonary hemorrhage complicating radiofrequency ablation, from mild hemoptysis to life-threatening pattern.  Eur Radiol. 2011;  21 (1) 197-204
• 10 Sano Y, Kanazawa S, Gobara H et al.. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience.  Cancer. 2007;  109 (7) 1397-1405
• 11 Steinke K, King J, Glenn D, Morris D L. Pulmonary hemorrhage during percutaneous radiofrequency ablation: a more frequent complication than assumed?.  Interact Cardiovasc Thorac Surg. 2003;  2 (4) 462-465
• 12 Steinke K, Sewell P E, Dupuy D et al.. Pulmonary radiofrequency ablation—an international study survey.  Anticancer Res. 2004;  24 (1) 339-343
• 13 Richardson C M, Pointon K S, Manhire A R, Macfarlane J T. Percutaneous lung biopsies: a survey of UK practice based on 5444 biopsies.  Br J Radiol. 2002;  75 (897) 731-735
• 14 Howenstein M J, Sato K T. Complications of radiofrequency ablation of hepatic, pulmonary, and renal neoplasms.  Semin Intervent Radiol. 2010;  27 (3) 285-295
• 15 Vaughn C, Mychaskiw II G, Sewell P. Massive hemorrhage during radiofrequency ablation of a pulmonary neoplasm.  Anesth Analg. 2002;  94 (5) 1149-1151
• 16 Duncan M, Wijesekera N, Padley S. Interventional radiology of the thorax.  Respirology. 2010;  15 (3) 401-412